Skip to content
All doctors
医师档案Doctor profileFeatured

Dr. Hu Yu

Director, Institute of Hematology; Chief Physician; Professor

基本信息At a glance

Where they practice, who they consult.

Hospital
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Experience
35+ years in hematology
Languages
English, Mandarin
专长Specialties

What they personally lead.

Hematologic malignanciesCAR-T cell therapy for B-cell lymphoma and multiple myelomathrombosis and hemostasis disorders
背景Background

Training and recognition

Past president of the Chinese Society of Hematology; led some of the earliest investigator-initiated CAR-T trials in China for relapsed/refractory B-cell malignancies; senior author on CAR-T outcome publications in Blood and Leukemia; chair of the Chinese Thrombosis and Hemostasis Society

国际患者International patients

What to expect

Tongji Wuhan is a high-volume academic CAR-T site. Suitable for patients with relapsed B-cell lymphoma, B-ALL, or multiple myeloma being evaluated for CD19, BCMA, or dual-target CAR-T therapy.

核实背景Verify credentials

Check the public record

Look up publications, citations, and academic profile on independent platforms before reaching out.

Results are automated searches and may include other individuals with similar names.

下一步Next step

Ask the AI or request a coordinator.

The AI can compare Hu Yu's background to other specialists in Wuhan. A coordinator can confirm appointment availability and English-language support.

Information is provided for reference only and may not reflect current conditions. Verify directly with the hospital before making decisions.